Middle-east Arab News Opinion | Asharq Al-awsat

nanoparticulate | ASHARQ AL-AWSAT English Archive 2005 -2017
Select Page
Media ID: 55351847
Caption:

: Cancer patient Stew Scannell receives an intravenous dose of Lambrolizumab during a promising cancer treatment clinical trial at UCLA Medical Center in Los Angeles, California August 19, 2013. Reuters